Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
As of the 28 January 2025 revision it is indicated not only for glycaemic control in type 2 diabetes, but also to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, and to reduce the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Identifying that diabetes is around the corner can help you stop it before it starts
By acting as an antioxidant, GHK-Cu may play a part in mitigating damage from free radicals, contributing to long-term health preservation
But in reality, the risk is so small it barely registers
US$ 20.03
US$ 29.89
US$ 24.81
US$ 26.92
US$ 27.72
US$ 22.51
US$ 20.64
US$ 25.44
US$ 20.48
US$ 26.00
US$ 20.75
US$ 23.70
